Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study - Concepedia

Concepedia

Publication | Closed Access

Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study

504

Citations

16

References

2019

Year

Julien Edeline, M. Benabdelghani, Aurélie Bertaut, J. Watelet, Pascal Hammel, Jean‐Paul Joly, Karim Boudjéma, Karine Bouhier‐Leporrier, Jean–Louis Jouve, Roger Faroux,

Journal of Clinical Oncology

Abstract

There was no benefit of adjuvant GEMOX in resected BTC despite adequate tolerance and delivery of the regimen.

References

	Year	Citations

Page 1